<DOC>
	<DOC>NCT01107236</DOC>
	<brief_summary>The purpose of this study is to assess the safety of IW-6118 when administered as a single oral dose to patients undergoing third molar extraction. Efficacy will be assessed in an exploratory manner.</brief_summary>
	<brief_title>Study to Evaluate Efficacy and Safety of IW-6118 in Patients Undergoing Third Molar Extraction</brief_title>
	<detailed_description />
	<mesh_term>Naproxen</mesh_term>
	<criteria>Between 18 and 30 years old at time of screening; BMI &gt; 18.5 and &lt; 30.0; In overall good health with no clinicallysignificant laboratory, ECG, or physical exam findings; Patient requires two ipsilateral third molar extractions of which one must be a full or partial bony mandibular impaction; Women of childbearing potential must have a negative pregnancy test and must agree to use doublebarrier contraception; Other inclusion criteria per protocol. History of any clinicallysignificant medical condition; Previous usage of prescription, OTC, or investigational drugs as per protocol requirements; Inadequate levels of pain to be included in the study; Other exclusion criteria per protocol.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>30 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Healthy subjects</keyword>
</DOC>